Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovasave in Active Refractory Crohn's Disease
NCT02327221Phase 2Terminated
- Sponsor
- TxCell
- Start
- Dec 2014
- Primary completion
- Nov 2016
- Modality
- Adoptive Cell Transfer
- Countries
- 6
01
Overview
A Phase 2 trial of Ovasave in Crohn's disease, sponsored by TxCell. Started Dec 2014; status: terminated.
02
Drugs
Ovasave
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02327221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02327221.